Briacell Therapeutics Corp (BCTX) Stock Price, Quote & News

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 921 1810

Fax: 604 921 1898

Website: briacell.com

Address:

Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

rp6577 Jun. 11 at 7:22 PM

$BCTX buyers putting up a fight

0 · Reply

Ares77manoe Jun. 11 at 7:05 PM

$BCTX adding like a pig

0 · Reply

letsdodiz Jun. 11 at 6:11 PM

$BCTX I’m buying more here . Wait is a few more months and odds are in Briacell’s favor.

0 · Reply

jcwhitey Jun. 11 at 4:57 PM

$BCTX Market is punishing all biotechs that are in developmental stage. BCTX, CHRS, RCKT, etc are all getting dumped because of higher interest rates. Even SMMT took a hit although they are raising funds but if interest rates rise these types of stocks tend to crash until they produce a product for approval. Hopefully BCTX will be ready in the next 6-12 months.

0 · Reply

AHA_OHO Jun. 11 at 4:11 PM

$BCTX Maybe... some bad news leaked.

2 · Reply

JediGreen Jun. 11 at 3:53 PM

$BCTX Must be 🤡 adding to there huge short position remember when the day comes when you have to cover all those. Phase 3 coming have fun covering on a gap properly around $20 just to begin covering 😆 clowns.

1 · Reply

rp6577 Jun. 11 at 3:51 PM

$BCTX feels like the shorts are taking a big risk here. The size of that recent raise really suggests management are expecting the 144 event to come before they need further capital. Otherwise I think they would have just raised more, as we’ve seen that they are not afraid to! I reckon 70% odds of data before raise

1 · Reply

FredFlintstock Jun. 11 at 3:45 PM

$BCTX dont worry they're just bringing the price down so it looks better for institutions. 🤣🤣🤣🤣

1 · Reply

Kirubin Jun. 11 at 2:46 PM

$BCTX definition of insanity The marjet has been talking to you LOUDLY and you’re still holding on to this shit! You will go down with the ship; at leats 🐀🐀jump out of it, but you will not🥶👏🏽💀😂

3 · Reply

dlev18 Jun. 11 at 1:56 PM

$BCTX just pray atp

0 · Reply

BriaCell Therapeutics Announces Closing of Offering

Mon, 01 Jun 2026 07:30:00 -0400 - 10 days ago

BriaCell Presents Positive Clinical Data at ASCO 2026

Sun, 31 May 2026 19:59:00 -0400 - 10 days ago

BriaCell Therapeutics Announces Pricing of Offering

2026-05-26T14:43:01.000Z - 16 days ago

BriaCell (BCTX) Receives Positive Update from Data Safety Monitoring Board

2026-05-26T13:05:39.000Z - 16 days ago

BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study

Tue, 26 May 2026 07:30:00 -0400 - 16 days ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

2026-05-22T13:27:19.000Z - 20 days ago

BriaCell (BCTX) Unveils Key Clinical Data at ASCO Annual Meeting 2026

2026-05-22T11:49:02.000Z - 20 days ago

BriaCell announces data from Bria-IMT at ASCO 2026

Fri, 22 May 2026 07:30:00 -0400 - 20 days ago

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026

Fri, 15 May 2026 07:30:00 -0400 - 27 days ago

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

2026-05-14T15:31:53.000Z - 4 weeks ago

BriaCell (BCTX) Completes Manufacturing for New Prostate Cancer Treatment

Thu, 14 May 2026 07:30:00 -0400 - 4 weeks ago

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer

2026-05-13T16:39:28.000Z - 4 weeks ago

BriaCell (BCTX) Expands Clinical Trial Network for Advanced Breast Cancer Treatment

2026-05-13T14:41:55.000Z - 4 weeks ago

BriaCell adds Penn Medicine as Phase 3 breast cancer study site

Wed, 13 May 2026 07:30:00 -0400 - 4 weeks ago

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Tue, 12 May 2026 07:30:00 -0400 - 4 weeks ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Thu, 07 May 2026 07:30:00 -0400 - 5 weeks ago

BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

2026-05-07T04:03:56.000Z - 5 weeks ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial

Wed, 06 May 2026 07:30:00 -0400 - 5 weeks ago

BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer

Mon, 27 Apr 2026 07:30:00 -0400 - 6 weeks ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

2026-04-21T13:28:43.000Z - 7 weeks ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T11:54:23.000Z - 7 weeks ago

BriaCell presents anti-cancer activity of Bria-OTS

Tue, 21 Apr 2026 07:30:00 -0400 - 7 weeks ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

2026-04-20T13:32:04.000Z - 7 weeks ago

BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting

2026-04-20T11:41:56.000Z - 7 weeks ago

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

Mon, 20 Apr 2026 07:30:00 -0400 - 7 weeks ago

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Tue, 31 Mar 2026 16:05:00 -0400 - 2 months ago

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

2026-03-18T13:30:56.000Z - 3 months ago

BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeting

2026-03-18T11:42:55.000Z - 3 months ago

BriaCell to present four posters at the 2026 AACR

Wed, 18 Mar 2026 07:30:00 -0400 - 3 months ago

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

Tue, 10 Mar 2026 07:30:00 -0400 - 3 months ago

BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 3 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

2026-02-18T22:51:30.000Z - 4 months ago

BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement

2026-02-18T22:35:25.000Z - 4 months ago

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

Wed, 18 Feb 2026 17:30:00 -0500 - 4 months ago

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

2026-02-17T12:40:59.000Z - 4 months ago

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

Tue, 17 Feb 2026 07:30:00 -0500 - 4 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

2026-01-28T13:30:56.000Z - 4 months ago

BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment

2026-01-28T12:40:40.000Z - 4 months ago

BriaCell says patient images show regression, resolution of metastsized tumors

Wed, 28 Jan 2026 07:30:00 -0500 - 4 months ago

BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

2026-01-27T13:32:37.000Z - 4 months ago

BriaCell (BCTX) Reports Promising Phase 2 Survival Data

2026-01-27T12:41:04.000Z - 4 months ago

BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer

Tue, 27 Jan 2026 07:30:00 -0500 - 4 months ago

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

2026-01-19T16:00:45.000Z - 5 months ago

Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?

2026-01-16T13:58:57.000Z - 5 months ago

Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch

Thu, 15 Jan 2026 16:05:00 -0500 - 5 months ago

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

2026-01-14T11:36:30.000Z - 5 months ago

What's Going On With BriaCell Therapeutics Stock Wednesday?

2026-01-14T11:19:44.000Z - 5 months ago

BriaCell Plunges On Pricing Announcement Of $30Mln Public Offering

2026-01-14T10:55:53.000Z - 5 months ago

BriaCell (BCTX) Unveils $30M Public Offering, Stock Dips 9.7%

2026-01-14T06:56:44.000Z - 5 months ago

BriaCell Therapeutics (BCTX) Launches $30M Public Offering

Jan 13, 2026, 9:00 PM EST - 5 months ago

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

2026-01-13T14:41:11.000Z - 5 months ago

BriaCell Therapeutics trading resumes

2026-01-13T14:35:29.000Z - 5 months ago

BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T12:35:49.000Z - 5 months ago

BriaCell reports sustained complete resolution of lung metastasis in Bria-OTS

Jan 13, 2026, 7:30 AM EST - 5 months ago

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

Dec 18, 2025, 7:30 AM EST - 6 months ago

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

2025-12-10T12:41:29.000Z - 6 months ago

BriaCell presents Phase 2, Phase 3 data on Bria-IMT at SABCS 2025

Dec 10, 2025, 7:30 AM EST - 6 months ago

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

2025-12-09T12:35:35.000Z - 6 months ago

BriaCell announces Phase 3 patient enrollment on track for 1H26 data readout

Dec 9, 2025, 7:30 AM EST - 6 months ago

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

2025-12-02T12:36:29.000Z - 6 months ago

BriaCell to present Phase 2 survival, Phase 3 data at SABCS 2025

Dec 2, 2025, 7:30 AM EST - 6 months ago

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

Nov 25, 2025, 7:30 AM EST - 7 months ago

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

2025-11-20T12:40:35.000Z - 7 months ago

BriaCell, Receptor.AI collaborate on AI small molecular cancer therapeutics

Nov 20, 2025, 7:30 AM EST - 7 months ago

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Nov 18, 2025, 7:30 AM EST - 7 months ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

Nov 7, 2025, 7:30 AM EST - 7 months ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Nov 4, 2025, 7:30 AM EST - 7 months ago

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

Oct 21, 2025, 7:50 AM EDT - 8 months ago

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

Oct 21, 2025, 7:30 AM EDT - 8 months ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

Oct 20, 2025, 7:30 AM EDT - 8 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 13, 2025, 7:30 AM EDT - 8 months ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

Oct 3, 2025, 7:30 AM EDT - 8 months ago

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

Aug 26, 2025, 7:30 AM EDT - 10 months ago

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

Aug 25, 2025, 7:30 AM EDT - 10 months ago

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

Aug 21, 2025, 12:00 PM EDT - 10 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 13, 2025, 7:30 AM EDT - 10 months ago

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Jul 31, 2025, 7:30 AM EDT - 11 months ago

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

Jul 30, 2025, 7:30 AM EDT - 11 months ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 29, 2025, 7:30 AM EDT - 11 months ago

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

Jul 25, 2025, 7:30 AM EDT - 11 months ago

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

Jul 16, 2025, 4:05 PM EDT - 11 months ago

BriaCell Therapeutics Announces Closing of $15 million Public Offering

Jul 15, 2025, 3:05 PM EDT - 11 months ago

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

Jul 15, 2025, 7:30 AM EDT - 11 months ago

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Jul 11, 2025, 7:30 AM EDT - 11 months ago

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

rp6577 Jun. 11 at 7:22 PM

$BCTX buyers putting up a fight

0 · Reply

Ares77manoe Jun. 11 at 7:05 PM

$BCTX adding like a pig

0 · Reply

letsdodiz Jun. 11 at 6:11 PM

$BCTX I’m buying more here . Wait is a few more months and odds are in Briacell’s favor.

0 · Reply

jcwhitey Jun. 11 at 4:57 PM

0 · Reply

AHA_OHO Jun. 11 at 4:11 PM

$BCTX Maybe... some bad news leaked.

2 · Reply

JediGreen Jun. 11 at 3:53 PM

1 · Reply

rp6577 Jun. 11 at 3:51 PM

1 · Reply

FredFlintstock Jun. 11 at 3:45 PM

$BCTX dont worry they're just bringing the price down so it looks better for institutions. 🤣🤣🤣🤣

1 · Reply

Kirubin Jun. 11 at 2:46 PM

3 · Reply

dlev18 Jun. 11 at 1:56 PM

$BCTX just pray atp

0 · Reply

2maligators Jun. 11 at 1:52 PM

$BCTX this is looking and feeling all too familiar when we had the last rs… 🤦🏻‍♂️ hopefully not 🙏🏼

2 · Reply

Kirubin Jun. 11 at 1:39 PM

$BCTX $BCTX blah blah blah blah! keep holding until $1 them RS fucking morons! But hey, i am the mean person here for pointing the obvious for years now! fucking aheep!

0 · Reply

BHWinehouse Jun. 11 at 10:30 AM

$BCTX

1 · Reply

JediGreen Jun. 11 at 7:27 AM

$BCTX https://youtu.be/RKGaXB4AyWs

1 · Reply

superguild Jun. 11 at 5:49 AM

$BCTX to quote the Doors. " Break on through to the downside"

0 · Reply

Rohtan Jun. 11 at 12:42 AM

$BCTX going below 2s in near future ?

2 · Reply

MoeMaze Jun. 10 at 12:09 PM

$BCTX WTF exactly r they doing with all the money !!!!

2 · Reply

rp6577 Jun. 10 at 8:02 AM

$BCTX I think we’ll get interim readout in October and they’ll still have cash through to early 2027 at that point. In which case I don’t think they’ll raise before the data and any shorts will be absolutely toast

0 · Reply

JediGreen Jun. 10 at 5:53 AM

$BCTX BriaCell Therapeutics Corp. Common Shares (BCTX) Short Interest | Nasdaq Wow getting close to 900k shares short. 😆 🤡 Have fun covering if things don’t go your way. https://www.nasdaq.com/market-activity/stocks/bctx/short-interest

1 · Reply

TopCharts Jun. 9 at 10:02 PM

$BCTX so company has maybe $27M cash and short term investments and they burn thru little over $7M per quarter. By October they will burn thru half of cash and be down to $13M which likely confirms another offering is coming later this year October or sooner. They have had two so far this year $30M and $5M.

2 · Reply

MoeMaze Jun. 9 at 9:37 PM

$BCTX WTF is wrong with this stock, with every good news it goes down, they submitted their quarterly report and it very good compared to the previous year and month …. Till when as***oles !!

1 · Reply

BHWinehouse Jun. 9 at 9:32 PM

$BCTX 10-Q is out https://app.quotemedia.com/data/downloadFiling?webmasterId=102691&ref=320119756&type=HTML&symbol=BCTX&cdn=a15b46203210301db74221920c74a5a8&companyName=BriaCell+Therapeutics+Corp.&formType=10-Q&formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&dateFiled=2026-06-09

0 · Reply

Market Cap	26.71M
Revenue (ttm)	0.00
Net Income (ttm)	-26.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	418,849
Avg Vol	214,634
Day's Range	N/A - N/A
Shares Out	8.70M
Stochastic %K	0%
Beta	1.21
Analysts	Strong Buy
Price Target	$40.00